CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,866,000 | +90212.7% | 2,100,000 | 0.0% | 3.29% | +3.7% |
| Q2 2023 | $68,502 | -7.3% | 2,100,000 | 0.0% | 3.18% | -12.5% |
| Q1 2023 | $73,899 | -99.9% | 2,100,000 | 0.0% | 3.63% | -28.4% |
| Q4 2022 | $96,222,000 | -5.4% | 2,100,000 | 0.0% | 5.07% | -11.3% |
| Q3 2022 | $101,745,000 | +23.3% | 2,100,000 | 0.0% | 5.72% | +9.5% |
| Q2 2022 | $82,509,000 | +6.7% | 2,100,000 | 0.0% | 5.23% | +31.5% |
| Q1 2022 | $77,301,000 | -19.2% | 2,100,000 | 0.0% | 3.97% | +6.9% |
| Q4 2021 | $95,718,000 | +27.5% | 2,100,000 | 0.0% | 3.72% | +41.9% |
| Q3 2021 | $75,054,000 | +80.6% | 2,100,000 | 0.0% | 2.62% | +78.8% |
| Q2 2021 | $41,559,000 | -14.9% | 2,100,000 | 0.0% | 1.47% | -11.5% |
| Q1 2021 | $48,846,000 | +11.9% | 2,100,000 | 0.0% | 1.66% | +18.1% |
| Q4 2020 | $43,638,000 | – | 2,100,000 | – | 1.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |